Placebo analgesia affects brain correlates of error processing

PLoS One. 2012;7(11):e49784. doi: 10.1371/journal.pone.0049784. Epub 2012 Nov 21.

Abstract

Placebo analgesia (PA) is accompanied by decreased activity in pain-related brain regions, but also by greater prefrontal cortex (PFC) activation, which has been suggested to reflect increases in top-down cognitive control and regulation of pain. Here we test whether PA is associated with altered prefrontal monitoring functions that could adjust nociceptive processing to a mismatch between expected and experienced pain. We recorded event-related potentials to response errors in a go/nogo task during placebo vs. a matched control condition. Error commission was associated with two well-described components, the error-related negativity (ERN) and the error positivity (Pe). Results show that the Pe, but not the ERN, was amplified during placebo analgesia compared to the control condition, with neural sources in the lateral and medial PFC. This Pe increase was driven by participants showing a placebo-induced change in pain tolerance, but was absent in the group of non-responders. Our results shed new light on the possible functional mechanisms underlying PA, suggesting a placebo-induced transient change in prefrontal error monitoring and control functions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Analgesia*
  • Brain Mapping
  • Cognitive Behavioral Therapy*
  • Electroencephalography
  • Evoked Potentials / drug effects
  • Female
  • Humans
  • Male
  • Nociceptive Pain / drug therapy
  • Nociceptive Pain / physiopathology
  • Pain Management*
  • Pain* / drug therapy
  • Pain* / physiopathology
  • Placebos / administration & dosage*
  • Prefrontal Cortex / drug effects
  • Reaction Time

Substances

  • Placebos

Grants and funding

LK was supported by the NCCR Affective Sciences financed by the Swiss National Science Foundation (n° 51NF40-104897) and hosted by the University of Geneva, as well as a travel stipend from the Network of European Neuroscience Schools (NENS). GP is supported by grants from the European Research Council (Starting Grant #200758) and Ghent University (BOF Grant #05Z01708). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.